CD4 and cervical cancer: Last but not least, we analyzed the expression of Tbet in CD4+Foxp3hi regulatory T cell clone 148.31, isolated from an HPV16+ cervical cancer patient with an ongoing local type 1 immune response, and for which we have shown its suppressive capacity in several different in vitro assays [26].